Why do Patients Stay in Opioid Maintenance Treatment?

REFERENCES

• Amato, L., Davoli, M., Perucci, C. A., Ferri, M., Faggiano, F., & Mattick, R. P. (2005). An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. Journal of Substance Abuse Treatment, 28(4), 321–329.
   PubMed Web of Science ®Google Scholar
• Apelt, S. M., Scherbaum, N., Golz, J., Backmund, M., & Soyka, M. (2013). Safety, effectiveness and tolerance of buprenorphine-naloxone in the treatment of opioid dependence: Results from a nationwide non-interventional study in routine care. Pharmacopsychiatry, 46(3), 94–107.
   PubMedGoogle Scholar
• Bart, G. (2012). Maintenance medication for opiate addiction: The foundation of recovery. Journal of Addictive Diseases, 31(3), 207–225.
   PubMed Web of Science ®Google Scholar
• Bell, J. & Mutch, C. (2006). Treatment retention in adolescent patients treated with methadone or buprenorphine for opioid dependence: a file review. Drug and Alcohol Review, 25(2), 167–171.
   PubMed Web of Science ®Google Scholar
• Bell, J., Trinh, L., Butler, B., Randall, D., & Rubin, G. (2009). Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment. Addiction, 104(7), 1193–1200.
   PubMed Web of Science ®Google Scholar
• Breslin, K.T. & Malone, S. (2006). Maintaining the viability and safety of the methadone maintenance treatment program. Journal of Psychoactive Drugs 38(2), 157–160.
   PubMed Web of Science ®Google Scholar
• Bukten, A., Skurtveit, S., Stangeland, P., Gossop, M., Willersrud, A. B., Waal, H., (2011). Criminal convictions among dependent heroin users during a 3-year period prior to opioid maintenance treatment: a longitudinal national cohort study. Journal of Substance Abuse Treatment, 41(4), 407–414.
   PubMed Web of Science ®Google Scholar
• Corsi, K. F., Lehman, W. K., & Booth, R. E. (2009). The effect of methadone maintenance on positive outcomes for opiate injection drug users. Journal of Substance Abuse Treatment , 37(2), 120–126.
   PubMed Web of Science ®Google Scholar
• Cruts, G., Buster, M., Vicente, J., Deerenberg, I., & Van Laar, M. (2008). Estimating the total mortality among problem drug users. Substance Use & Misuse, 43(5), 733–747.
   PubMed Web of Science ®Google Scholar
• Dang, V. C. & Christie, M. J. (2012). Mechanisms of rapid opioid receptor desensitization, resensitization and tolerance in brain neurons. British Journal of Pharmacology, 165(6), 1704–1716.
   PubMed Web of Science ®Google Scholar
• Dole, V. P. (1972). Detoxification of sick addicts in prison. The Journal of the American Medical Association, 220, 366–369.
   PubMed Web of Science ®Google Scholar
• Dole, V. P. & Joseph, H. (1977). Methadone maintenance. Outcome after termination. New York State Journal of Medicine , 77(9), 1409–1412.
   PubMedGoogle Scholar
• Dole, V. P. & Joseph, H. (1978). Long-term outcome of patients treated with methadone maintenance. Annals of the New York Academy of Sciences, 311, 181–189.
   PubMedGoogle Scholar
• Dole, V. P., & Nyswander, M. (1965). A medical treatment for diacetylmorphine (Heroin) addiction. A clinical trial with methadone hydrochloride. The Journal of the American Medical Association, 193, 646–650.
   PubMed Web of Science ®Google Scholar
• Dole, V. P., Nyswander, M. E., & Kreek, M. J. (1966). Narcotic blockade—a medical technique for stopping heroin use by addicts. Transactions of the Association of American Physicians, 79, 122–136.
   PubMedGoogle Scholar
• Farrell, M., Ward, J., Mattick, R., Hall, W., Stimson, G. V., des Jarlais, D., (1994). Methadone maintenance treatment in opiate dependence: a review. British Medical Journal, 309(6960), 997–1001.
   PubMed Web of Science ®Google Scholar
• Gronbladh, L., Ohlund, L. S., & Gunne, L. M. (1990). Mortality in heroin addiction: impact of methadone treatment. Acta Psychiatrica Scandinavica, 82(3), 223–227.
   PubMed Web of Science ®Google Scholar
• Hall, W., Ward, J., & Mattick, R. P. (1998). The effectiveness of methadone maintenance treatment: heroin use and other crime. Methadone maintenance treatment and other opioid replacement therapies. J. Ward, R. P. Mattick & W. Hall (Ed.), Amsterdam: Harwood Academic, 17–58.
   Google Scholar
• Huang, C. L., & Chung-Wei, L. (2013). Factors associated with mortality among heroin users after seeking treatment with methadone: A population-based cohort study in Taiwan. Journal of Substance Abuse Treatment,44(3), 295–300.
   PubMedGoogle Scholar
• Jimenez-Trevino, L., Saiz, P. A., Garcia-Portilla, M. P., Diaz-Mesa, E. M., Sanchez-Lasheras, F., Buron, P., (2011). A 25-year follow-up of patients admitted to methadone treatment for the first time: mortality and gender differences. Addictive Behaviors, 36(12), 1184–1190.
   PubMed Web of Science ®Google Scholar
• Joseph H. (2012). Lisa Mojer-Torres, ESQ (December 1, 1956-April 7, 2011). Journal of Addictive Diseases, 31(3), 197–198.
   PubMed Web of Science ®Google Scholar
• Joseph, H. & Appel, P. (1985). Alcoholism and methadone treatment: Consequences for patient and program. The American Journal of Drug and Alcohol Abuse, 11(1&2), 37–53.
   PubMedGoogle Scholar
• Joseph, J., Appel, P., & Schneidler, J. (1981). Death during and after discharge from methadone maintenance treatment. Albany (NY): New York State Office of Alcoholism and Substance Abuse Sevices. Outcome Study report #1.
   Google Scholar
• Kimber, J., Copeland, L., Hickman, M., Macleod, J., McKenzie, J., De Angelis, D., (2010). Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment. British Medical Journal, 341, c3172.
   PubMed Web of Science ®Google Scholar
• Kornor, H., & Waal, H. (2005). From opioid maintenance to abstinence: A literature review. Drug and Alcohol Review, 24(3), 267–274.
   PubMed Web of Science ®Google Scholar
• Kreek, M. J., & Vocci, F. J. (2002). History and current status of opioid maintenance treatments: blending conference session. Journal of Substance Abuse Treatment, 23(2), 93–105.
   PubMed Web of Science ®Google Scholar
• Latowski, M. (2006). Methadone death, dosage and torsade de pointes: risk-benefit policy implications. Journal of Psychoactive Drugs, 38(4), 513–519.
   PubMedGoogle Scholar
• Lua P.L., Talib, N. S. (2012). A 12-month evaluation of health-related quality of life outcomes of methadone maintenance program in a rural Malaysian sample. Substance Use & Misuse, 47(10), 1100–1105. Epub 2012 May 1.
   PubMed Web of Science ®Google Scholar
• Magura, S., & Rosenblum, A. (2001). Leaving methadone treatment: lessons learned, lessons forgotten, lessons ignored. Mount Sinai Journal of Medicine, 68(1), 62–74.
   PubMed Web of Science ®Google Scholar
• Martin, W. R. & Jasinski, D. R. (1969). Physiological parameters of morphine dependence in man–tolerance, early abstinence, protracted abstinence. Journal of Psychiatric Research, 7(1), 9–17.
   PubMedGoogle Scholar
• McKeganey, N., Russell, C. & Cockayne, L. (2013). Medically assisted recovery from opiate dependence within the context of the UK drug strategy: methadone and Suboxone (buprenorphine-naloxone) patients compared. Journal of Substance Abuse Treatment, 44(1), 97–102.
   PubMedGoogle Scholar
• Metzger, D. S., Woody, G. E., McLellan, A. T., O'Brien, C. P., Druley, P., Navaline, H., (1993). Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. Journal of Acquired Immune Deficiency Syndromes, 6, 1049–1056.
   PubMed Web of Science ®Google Scholar
• Milby, J. B. (1988). Methadone maintenance to abstinence. How many make it? The Journal of Nervous and Mental Disease, 176(7), 409–422.
   PubMed Web of Science ®Google Scholar
• Millman, R. B., Khuri, E. T. & Nyswander, M. E. (1978). Therapeutic detoxification of adolescent heroin addicts. Annals of the New York Academy of Sciences, 311, 153–164.
   PubMedGoogle Scholar
• National Consensus Developmental Panel on Effective Treatment of Opiate Addiction. (1998). Effective medical treatment of opiate addiction. The Journal of the American Medical Association, 280(22), 1936–1943.
   Google Scholar
• Pecoraro, A., Ma, M., & Woody, G.E. (2012). The science and practice of medication-assisted treatments for opioid dependence. Substance Use & Misuse, 47(8–9), 1026–1040.
   Google Scholar
• Quillinan, N., Lau, E. K., Virk, M., von Zastrow, M., & Williams, J. T. (2011). Recovery from mu-opioid receptor desensitization after chronic treatment with morphine and methadone. The Journal of Neuroscience, 31(12), 4434–4443.
   PubMed Web of Science ®Google Scholar
• Richardson, L., Wood, E., Montaner, J., & Kerr, T. (2012). Addiction treatment-related employment barriers: The impact of methadone maintenance. Journal of Substance Abuse Treatment, 43(3), 276–284.
   PubMed Web of Science ®Google Scholar
• Sees, K. L., Delucchi, K. L., Masson, C., Rosen, A., Clark, H. W., Robillard, H., (2000). Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: A randomized controlled trial. The Journal of the American Medical Association, 283(10), 1303–1310.
   PubMed Web of Science ®Google Scholar
• Smyth, B. P., Fagan, J., & Kernan, K. (2012). Outcome of heroin-dependent adolescents presenting for opiate substitution treatment. Journal of Substance Abuse Treatment, 42(1), 35–44.
   PubMedGoogle Scholar
• Strike, C. J., Gnam, W., Urbanoski, K., Fischer, B., Marsh, D. C., & Millson, M. (2005). Factors predicting 2-year retention in methadone maintenance treatment for opioid dependence. Addictive Behaviors, 30(5), 1025–1028.
   PubMed Web of Science ®Google Scholar
• Tkacz, J., Severt, J., Cacciola, J., & Ruetsch, C. (2012). Compliance with buprenorphine medication-assisted treatment and relapse to opioid use. American Journal on Addictions, 21(1), 55–62.
   PubMed Web of Science ®Google Scholar
• Walley, A. Y., Cheng, D. M., Pierce, C. E., Chen, C., Filippell, T., Samet, J. H., (2012). Methadone dose, take home status, and hospital admission among methadone maintenance patients. Journal of Addiction Medicine, 6(3), 186–90.
   PubMedGoogle Scholar
• Ward, J., Hall, W., & Mattick, R. P. (1999). Role of maintenance treatment in opioid dependence. Lancet, 353(9148), 221–226.
   PubMed Web of Science ®Google Scholar
• Weiss, R. D., Potter, J. S., Fiellin, D. A., Byrne, M., Connery, H. S., Dickinson, W., (2011). Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. Archives of General Psychiatry, 68(12), 1238–1246.
   PubMed Web of Science ®Google Scholar
• White, W. L. (2012). Medication-assisted recovery from opioid addiction: historical and contemporary perspectives. Journal of Addictive Diseases, 31(3), 199–206.
   PubMed Web of Science ®Google Scholar
• Woods, J. S. & Joseph, H. (2012). Reducing stigma through education to enhance medication-assisted recovery. Journal of Addictive Diseases, 31(3), 226–235.
   PubMed Web of Science ®Google Scholar